HUMAN FIBRINOGEN
Intracranial Hemorrhages
Azienda Usl di Bolognaprotein_peptidePhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
39 Active assets in the Intracranial Hemorrhages cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Edoxaban Population Health Research Institute | Phase 4 | BBB |
Tranexamic Acid Christian Medical College and Hospital, Ludhiana, India | Phase 4 | BB |
Acetylsalicylic Acid University Hospital, Lille | Phase 4 | BB |
Rivaroxaban Imperial College London | Phase 3 | BB |
Tenecteplase Gaurav Gupta, MD | Phase 3 | BB |
View all 50 →
Same molecule, other indications
HUMAN FIBRINOGEN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →